RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BURLONE ME
Collezione AOU Novara

Items : 13

From MASH to HCC: the role of Gas6/TAM receptors. in Frontiers in immunology / Front Immunol. 2024 Jan 17;15:1332818. doi: 10.3389/fimmu.2024.1332818. eCollection 2024.

2024
AOU Novara

Apostolo D; Ferreira LL; Vincenzi F; Vercellino N; Minisini R; Latini F; Ferrari B; Burlone ME; Pirisi M; Bellan M;

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development. in Biology / Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094.

2023
AOU Città della Salute di Torino
AOU Novara

Bugianesi E; Saracco GM; Minisini R; Olivero A; Armandi A; Rosso C; Musso EC; Crevola M; Albè A; Burlone ME; Risso A; Rolle E; Carucci P; Troshina G; Abate ML; Caviglia GP; Pirisi M; Ciancio A; Gaia S;

Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. in Cancers / Cancers (Basel). 2023 Jan 6;15(2):381. doi: 10.3390/cancers15020381.

2023
AOU Novara

Giacomelli L; Papa S; Giordano G; Dadduzio V; Gadaleta-Caldarola G; Paolillo R; Giannini EG; Pieri G; Mega A; Granito A; Marzi L; Masi G; Cesario S; Rancatore G; Cabibbo G; Cocuzza C; Russello M; Gallo P; Silletta M; Daniele B; Federico P; Pirisi M; Burlone ME; di Costanzo GG; Tortora R; Ramai D; Sacco R; Renzulli M; Maida M; et alii...

HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment. in Clinical journal of gastroenterology / Clin J Gastroenterol. 2022 Apr;15(2):301-309. doi: 10.1007/s12328-021-01578-1. Epub 2022 Jan 31.

2022
AOU Novara

Burlone ME; Bellan M; Barbaglia MN; Mocchetti G; Mallela VR; Minisini R; Rigamonti C; Pirisi M;

Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis. in Journal of digestive diseases / J Dig Dis. 2021 Aug;22(8):496-502. doi: 10.1111/1751-2980.13030. Epub 2021 Jul 13.

2021
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Pirisi M; Berchialla P; Tabone M; Mattalia A; Burlone ME; Okolicsanyi S; Gaia S; Rolle E; Gesualdo M; Carucci P; Ricotti A; Martelletti C;

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients. in Gastroenterology research and practice / Gastroenterol Res Pract. 2020 Apr 24;2020:4216451. doi: 10.1155/2020/4216451. eCollection 2020.

2020
AOU Novara

De Benedittis C; Bellan M; Crevola M; Boin E; Barbaglia MN; Mallela VR; Ravanini P; Ceriani E; Fangazio S; Sainaghi PP; Burlone ME; Minisini R; Pirisi M;

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders. in Disease markers / Dis Markers. 2020 May 12;2020:2696173. doi: 10.1155/2020/2696173. eCollection 2020.

2020
ASL Novara
AOU Novara

Sola D; Marino P; Castello LM; Barbaglia MN; Salmi L; Minisini R; Rigamonti C; Burlone ME; Smirne C; Carriero A; Barini M; Nerviani A; Grimoldi F; Sguazzotti M; Giubertoni A; Ianniello A; Piccinino C; Dimagli A; Bellan M; Avanzi GC; Pirisi M; Sainaghi PP;

Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease. in Gastroenterology research and practice / Gastroenterol Res Pract. 2019 Dec 23;2019:6731498. doi: 10.1155/2019/6731498. eCollection 2019.

2019
AOU Novara

Bellan M; Rigamonti C; Giacomini GM; Makmur G; Marconi C; Nicosia F; Panero A; De Benedittis C; Burlone ME; Minisini R; Pirisi M;

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. in Disease markers / Dis Markers. 2019 Sep 8;2019:2304931. doi: 10.1155/2019/2304931. eCollection 2019.

2019
AOU Novara

Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC;

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders. in Disease markers / Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

2019
ASL Vercelli
AOU Novara

Pirisi M; Marino P; Sola D; Smirne C; Burlone ME; Sguazzotti M; Grimoldi F; Dimagli A; Piccinino C; Giubertoni A; Bellan M; Sainaghi PP;

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents. in PloS one / PLoS One. 2018 Dec 20;13(12):e0209216. doi: 10.1371/journal.pone.0209216. eCollection 2018.

2018
ASL Vercelli
AOU Novara

Bellomo G; Favretto S; Re A; Bianco S; Bonometti R; Burlone ME; Rigamonti C; Tran Minh M; Smirne C; Bellan M; Gualerzi A; Minisini R; Carnevale Schianca GP; Pirisi M;

Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C. in Annals of gastroenterology / Ann Gastroenterol. 2017;30(6):675-681. doi: 10.20524/aog.2017.0190. Epub 2017 Sep 6.

2017
ASL Vercelli
AOU Novara

Pirisi M; Franzosi L; Favretto S; Burlone ME; Giarda P; Minisini R; Bellan M; Marconi C;

Toxocara encephalitis presenting with autonomous nervous system involvement. in Infection / Infection. 2013 Jun;41(3):691-4. doi: 10.1007/s15010-012-0342-6. Epub 2012 Sep 21.

2013
AOU Novara

Caldera F; Burlone ME; Genchi C; Pirisi M; Bartoli E;